Accuracy of pepsinogens for early diagnosis of atrophic gastritis and gastric cancer in Iranian population

Medical Journal of the Islamic Republic of Iran

Volumn 28, Issue 1, 2014, Pages

  Zoalfaghari, Abbas ^a   Aletaha, Najmeh ^a   Roushan, Nader ^a   Taslimi, Reza ^b   Foroutan, Hossein ^b   Faridnia, Bita ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NONE   (Iran)

Author keywords

Atrophic gastritis; Biomarkers; Gastric cancer; Pepsinogens

Indexed keywords

EID: 84969301274     PISSN: 10161430     EISSN: 22516840     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002; 52: 23-47.
2. Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S. Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan. Int J Cancer 2006,1(118) :2315-2321.
3. Tashiro A, Sano M, Kinameri K, Fujita K, Takeuchi Y. Comparing mass screening techniques for gastric cancer in Japan. World J Gastroenterol 2006; 14(12):4873-4874.
4. Sipponen P, Härkönen M, Alanko A et al. Diagnosis of atrophic gastritis from a serum sample. Clin Lab 2002; 48: 505-15.
5. Suovaniemi O, Härkönen M, Paloheimo L et al. Diagnosis of atrophic gastritis from a serum sample. Jordan Med J 2002; 36: 117-21.
6. Mardh E, Mardh S, Mardh B, et al. Diagnosis of gastritis by means of a combination of serological analyses. Clin Chim Acta 2002; 320: 17-27.
7. So JB-Y, Yeoh K-G, Moochala S, et al. Serum pepsinogen levels in gastric cancer patients and their relationship with Helicobacter pylori infection: a prospective study. Gastric Cancer 2002; 5: 228-32.
8. Yoshihara M, Hiyama T, Yoshida S, Ito M, Tanaka S, Watanabe Y, et al. Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study. Scand J Gastroenterol 2007; 42:760-764.
9. Dixon FM, Genta RM, Yardley JH et al. Classification and grading of gastritis: The updated Sydney System. Am J Surg Pathol 1996; 20: 1161-81.
10. Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther. 2002;16(7):1249-59.
11. Correa P. The epidemiology of gastric cancer. World J Surg 1991; 15:228-234.
12. Islami F, Kamangar F, Aghcheli K, et al. Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer 2004;90:1402-1406.
13. Oksanen A, Sipponen P, Miettinen A, Sarna S, Rautelin H. Evaluation of blood tests to predict normal gastric mucosa. Scand J Gastroenterol 2000; 35:791-5.
14. Schlemper RJ, van der Werf SD, Biemond I, Lamers CB. Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease. Eur J Gastroenterol Hepatol 1996; 8:33-9.
15. Sipponen P, Ranta P, Helske T, et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol 2002;37:785-91.
16. Brenner H, Rothenbacher D, Weck MN. Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff-value. Int J Cancer 2007; 15 (121):2782-2786.
17. Hattori Y, Tashiro H, Kawamoto T, Kodama Y. Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens. Jpn J Cancer Res 1995; 86:1210-1215.
18. Kikuchi S, Kato M, Katsuyama T, Tominaga S, Asaka M. Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection. Helicobacter 2006;11:147-151.
19. Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999; 44:693-697.
20. Hosseini M, Amoueian S, Attaranzadeh A, Montazer M, Soltani GH, Asadollahi KH, Abangah GH. Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran. Journal of Research in Medical Sciences 2013;225-229.
21. Haj-Sheykholeslami A, Rakhshani N, Amirzargar A, Rafiee R, Shahidi SM, Nikbin B, et al. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: Comparative study with type and severity of gastritis. Clin Gastroenterol Hepatol 2008;6:174-9.
22. Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Shakeri R, Persson EC, Islami F, et al. Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: Influence of gastritis. PLoS One 2011;6:e26957.
23. Irvani S, Hashemi MR, Moghadam KG, Saeidee S, Khavaran K, Najari O, et al. Accuracy of serum pepsinogens I and II, gastrin-17 and antihelicobacter pylori antibodies in histological diagnoses of atrophic gastritis. Minerva Gastroenterol Dietol. 2010 Mar;56(1):13-7.
24. Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol. 2008; 43 (12):1448-55.
25. Graham DY, Nurgalieva ZZ, El-Zimaity HM, Opekun AR, Campos A, et al. Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America. Clin Gastroenterol Hepatol 2006;4: 306-314.
26. Broutet N, Plebani M, Sakarovitch C, Sipponen P, Megraud F. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer 2003; 88: 1239-1247.
27. Kang JM, Kim N, Yoo JY, Park YS, Lee DH, et al. The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea. Helicobacter 2008;13: 146-156.